FDA: Aleve May Be Safer on Heart Than Rival Drugs

FDA: Aleve May Be Safer on Heart Than Rival Drugs

The FDA meeting is the latest chapter in an ongoing safety review of NSAIDs that stretches back to 2004, when Merck & Co Inc. pulled its blockbuster pain reliever Vioxx off the market due to links to heart attack and stroke. Vioxx was part of a subset

2
Like
Save

Comments

Write a comment

*